Conference Reports for NATAP

66th Annual Meeting of the American Association for the Study of Liver Diseases Boston, MA Nov 13-17 2015 Back

Sofosbuvir Plus Ribavirin Without Interferon for Treatment of Acute HCV in HIV-1 Infected Individuals: SWIFT-C....Harvoni 8 weeks enrolling       Reported by Jules Levin AASLD 2015 Nov 13-17 San Francisco   Susanna Naggie1, Kristen M. Marks2, Michael Hughes3, Daniel S. Fierer4, Arthur Kim5, Kimberly Hollabaugh3, Jennifer Kiser6, Jhoanna Roa7, Bill Symonds8, Diana M. Brainard9, John G. McHutchison9, Marion G. Peters10, Raymond T. Chung5 1Duke University Medical Center, Durham, NC, United States, 2Weill Cornell, New York, NY, United States, 3Harvard, Cambridge, MA, United States, 4Icahn School of Medicine at Mount Sinai, New York, NY, United States, 5Massachusetts General Hospital, Boston, MA, United States, 6University of Colorado, Denver, CO, United States, 7Social & Scientific Systems, Inc., Silver Spring, MD, United States,8Roivant, New York, NY, United States, 9Gilead Sciences, Inc, Foster City, CA, United States, 10University of California, San Francisco, San Francisco, CA, United States.